Related Experiment Videos
Maternal alloimmunization against fetal platelet antigens: a prospective study
S Panzer1, L Auerbach, E Cechova
1Clinical Department for Blood Group Serology, University of Vienna, Austria.
British Journal of Haematology
|July 1, 1995
Summary
Neonatal alloimmune thrombocytopenia (NAIT) risk from HPA-2 and HPA-3 antibodies is low. HLA types do not predict NAIT risk for HPA-1 or HPA-5, and maternal anti-HPA-5b doesn't affect neonatal platelet counts.
Area of Science:
- Immunology
- Perinatology
- Hematology
Background:
- Neonatal alloimmune thrombocytopenia (NAIT) is a serious condition caused by maternal antibodies attacking fetal platelets.
- Understanding the incidence and predictors of NAIT is crucial for preventing adverse neonatal outcomes.
Purpose of the Study:
- To evaluate the incidence of anti-platelet antibodies in mother-child pairs.
- To assess the correlation between specific human platelet antigens (HPA) antibodies and neonatal outcomes.
- To investigate the role of HLA allotypes in predicting NAIT risk.
Main Methods:
- Prospective study of 933 mother-child pairs.
- Typing for human platelet antigens (HPA)-1, -2, -3, -5.
- Screening for anti-platelet, anti-HLA class I, and anti-ABO IgG antibodies in mismatched pairs.
Main Results:
- Low incidence of NAIT due to HPA-2 and HPA-3 alloimmunization.
- Anti-HPA-5b antibodies detected in 17 neonates, all with normal platelet counts.
- HLA allotypes did not predict NAIT risk for HPA-1 or HPA-5; maternal anti-HPA-5b did not correlate with neonatal platelet count.
Conclusions:
- The risk for NAIT due to HPA-2 and HPA-3 alloimmunization is low.
- HLA allotypes are not reliable predictors for NAIT risk associated with HPA-1 or HPA-5.
- Maternal anti-HPA-5b antibodies do not impact neonatal platelet counts in NAIT.